To see the other types of publications on this topic, follow the link: Dermatological respiratory syndrome.

Journal articles on the topic 'Dermatological respiratory syndrome'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Dermatological respiratory syndrome.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Shionoya, Yoshiki, Maki Yamamoto, Katsuhisa Sunada, and Kiminari Nakamura. "Anesthetic Management of a Pediatric Patient With Cardiofaciocutaneous Syndrome." Anesthesia Progress 67, no. 1 (2020): 45–47. http://dx.doi.org/10.2344/anpr-67-01-07.

Full text
Abstract:
Cardiofaciocutaneous (CFC) syndrome is a rare condition characterized by congenital heart disease, craniofacial dysmorphology, and dermatological abnormalities. CFC syndrome is one of the RASopathies, a family of syndromes that also includes Noonan and Costello syndromes, all with underlying gene mutations involving the Ras/mitogen-activated protein kinase pathways. Important considerations for anesthesiologists caring for these patients include the need to evaluate for possible cardiac defects, anticipating and planning for potentially difficult airway management, and the consideration of pot
APA, Harvard, Vancouver, ISO, and other styles
2

Kamra, Nidhi, and Ankita Tuknayat. "Apert syndrome: A dermatologist’s perspective." CosmoDerma 1 (December 16, 2021): 66. http://dx.doi.org/10.25259/csdm_64_2021.

Full text
Abstract:
Apert syndrome is a Type 1 acrocephalosyndactyly syndrome presenting predominantly with craniofacial malformations and syndactyly. It can present with a multitude of clinical features involving any system of the body. A literature search of the PubMed electronic database was performed using the keywords “Apert syndrome” and “dermatology” in the title. The relevant references of the included articles were traced and included. A total of 27 articles appeared, the abstracts of which were screened and reviewed by both the authors independently for inclusion. After carefully analyzing all papers ca
APA, Harvard, Vancouver, ISO, and other styles
3

M., Dheemant, Sushmitha E. S., Madhan Jeyaraman, Ajay S. S., and Rashmi Jain. "Unveiling the dermatological manifestations of nCOVID-19." International Journal of Research in Dermatology 6, no. 4 (2020): 597. http://dx.doi.org/10.18203/issn.2455-4529.intjresdermatol20202024.

Full text
Abstract:
<p class="abstract">Coronaviruses are RNA viruses that have become a major public health concern since the severe acute respiratory syndrome CoV (SARS-CoV-2) outbreak in 2002. The continuous evolution of coronaviruses was further highlighted with the emergence of the middle east respiratory syndrome CoV (MERS-CoV) outbreak in 2012. The spike glycoprotein of SARS-CoV-2 plays a pivotal role in the entry of virus into the cell and it further interacts with ACE-II receptors which are widely distributed on the human cell surface especially on alveolar type II cells (AT-2) and endothelium. Cur
APA, Harvard, Vancouver, ISO, and other styles
4

Nemchaninova, O. B., and Е. P. Simonova. "Dermatological manifestations associated with a novel coronavirus infection in the acute and post-acute period of COVID-19." Journal of Siberian Medical Sciences 7, no. 1 (2023): 7–17. http://dx.doi.org/10.31549/2542-1174-2023-7-1-7-17.

Full text
Abstract:
Introduction. Dermatological manifestations of a novel coronavirus infection caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are observed in the different periods of the disease, and can sometimes be the only manifestation of coronavirus disease 2019 (COVID-19). Despite the fact that at present the daily increase in new cases of coronavirus infection in the Russian Federation is small, the issues of timely diagnosis, treatment and prevention of COVID-19 remain relevant, and the experience gained during the pandemic is of invaluable practical importance. Aim. Evaluati
APA, Harvard, Vancouver, ISO, and other styles
5

McGuire, Joseph, and Saif Al-Qatarneh, MD. "Cardio-Facio-Cutaneous Syndrome with an Unusual Presentation of Respiratory Failure Requiring Tracheostomy and Long-term Ventilation." West Virginia Medical Journal 119, no. 4 (2023): 16–17. http://dx.doi.org/10.21885/wvmj.2023.18.

Full text
Abstract:
Cardio-facio-cutaenous (CFC) syndrome is a phenotypically diverse disorder that is caused by mutations in the RAS/MEK/ERK signaling pathway, sharing many clinical similarities with Noonan and Costello syndromes. Classic findings of CFC include congenital cardiac anomalies, dysmorphic facial features, dermatological manifestations, and other multisystemic abnormalities. Laryngomalacia, generalized muscle weakness, and hypotonia have been reported phenotypical variants of the disorder. We describe a case of a male newborn with a genetic diagnosis of CFC syndrome who presented with respiratory fa
APA, Harvard, Vancouver, ISO, and other styles
6

Pendlebury, Gehan A., Peter Oro, William Haynes, Drew Merideth, Samantha Bartling, and Michelle A. Bongiorno. "The Impact of COVID-19 Pandemic on Dermatological Conditions: A Novel, Comprehensive Review." Dermatopathology 9, no. 3 (2022): 212–43. http://dx.doi.org/10.3390/dermatopathology9030027.

Full text
Abstract:
Background: The earliest cases of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, in December 2019. Since the declaration as a pandemic on 11 March 2020, further dermatological conditions continue to be documented. We herein present a novel literature review of dermatological manifestations associated with the Coronavirus Disease 2019 (COVID-19) pandemic. To date, this literature review is the first broad-spectrum examination that analyzes a range of dermatological manifestations related to the COVID-19 pandemic: infection, vaccinations, personal protectiv
APA, Harvard, Vancouver, ISO, and other styles
7

Khondker, Lubna, Md Shirajul Islam Khan, and Abu Reza Sayem Ahamed. "Dermatological Manifestations of COVID-19 Patients." International Journal of Advanced Multidisciplinary Research and Studies 4, no. 3 (2024): 186–90. http://dx.doi.org/10.62225/2583049x.2024.4.3.2762.

Full text
Abstract:
Background: COVID-19 is a highly contagious respiratory tract infection caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), was first identified in China, in December 2019. Almost 10% of the patients develop dermatological manifestations before the onset of respiratory illness, with cutaneous signs that can appear from before to several days after the diagnosis of COVID-19. We believe that the dermatologist can play an important role through early recognition of skin lesions suggestive of COVID-19, particularly in asymptomatic infections where this recognition could direct
APA, Harvard, Vancouver, ISO, and other styles
8

Fernández-Lázaro, Diego, and Manuel Garrosa. "Identification, Mechanism, and Treatment of Skin Lesions in COVID-19: A Review." Viruses 13, no. 10 (2021): 1916. http://dx.doi.org/10.3390/v13101916.

Full text
Abstract:
Coronavirus disease 2019 (COVID-19) is a multisystem disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), that primarily causes respiratory symptoms. However, an increasing number of cutaneous manifestations associated with this disease have been reported. The aim of this study is to analyze the scientific literature on cutaneous manifestations associated with SARS-CoV-2 by means of a narrative literature review until June 2021. The search was conducted in the following electronic databases: Medline (PubMed), SciELO, and Cochrane Library Plus. The most common cutaneo
APA, Harvard, Vancouver, ISO, and other styles
9

Markiewicz-Gospodarek, Agnieszka, Paulina Wdowiak, Marcin Czeczelewski, et al. "The Impact of SARS-CoV-2 Infection on Fertility and Female and Male Reproductive Systems." Journal of Clinical Medicine 10, no. 19 (2021): 4520. http://dx.doi.org/10.3390/jcm10194520.

Full text
Abstract:
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection remains a huge challenge for contemporary healthcare systems. Apart from widely reported acute respiratory distress syndrome (ARDS), the virus affects many other systems inducing a vast number of symptoms such as gastrointestinal, neurological, dermatological, cardiovascular, and many more. Currently it has also been hypothesized that the virus might affect female and male reproductive systems; SARS-CoV-2 infection could also have a role in potential disturbances to human fertility. In this article, we aimed to review t
APA, Harvard, Vancouver, ISO, and other styles
10

Chandni P. Daryanani, Theresia Monica Rahardjo, Harris Utama, Angga Trie Buana, Eaufira Mereditha Pasaribu, and Euodia Eunike. "Multisystem Inflammatory Syndrome in Children: A Review." Medical Clinical Update 2, no. 1 (2023): 19–23. http://dx.doi.org/10.58376/mcu.v2i1.26.

Full text
Abstract:
Pediatric inflammatory multisystem syndrome, temporally associated with SARS-CoV-2 (PIMS-TS) or multisystem inflammatory syndrome in children (MIS-C) is a condition identified recently. Children who were previously healthy may experience cardiac, neurological, respiratory, gastrointestinal, and dermatological dysfunction. Majority of patients (73%) require intensive care treatment, and more than half (56%) of patients arrive in shock. Different management are used for MIS-C patients, but they all primarily focus on immunomodulatory drugs such as IVIG and glucocorticoids as initial therapy. Bio
APA, Harvard, Vancouver, ISO, and other styles
11

Soltani, Marziyeh, Fatemeh Abdi, and Somayeh Shahsavari. "Exploring Dermatological Complications of Drugs Used in Acute Respiratory Syndrome Coronavirus 2 Treatment: A Mini Review." Journal of Biochemicals and Phytomedicine 3, no. 1 (2024): 8–13. https://doi.org/10.34172/jbp.2024.4.

Full text
Abstract:
The COVID-19 pandemic has presented unprecedented challenges to governments and populations worldwide, triggering a global health crisis within months. In response, international health research organizations have highlighted various effects of chemical therapies, including dermatological complications. This mini-review explores the dermatological effects of drugs used in the treatment of COVID-19. This study examines the skin manifestations resulting from standard chemical treatments administered during the COVID-19 pandemic. Keywords were cross-referenced across multiple databases, including
APA, Harvard, Vancouver, ISO, and other styles
12

Mukurala, Swathi, Jahanavi Bandla, and Swetha kappala. "Angioedema-post COVID symptoms." AIMS Allergy and Immunology 7, no. 4 (2023): 273–80. http://dx.doi.org/10.3934/allergy.2023018.

Full text
Abstract:
<abstract> <p>The non-respiratory symptoms associated with coronavirus disease 2019 (COVID-19) are being reported more frequently as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreads throughout the world. Numerous dermatological issues have been connected to this viral infection. Angioedema has been reported by the patients post COVID. In this article, we discuss cases that have been reported in the medical literature and give a case study of angioedema that might be because of COVID-19 infection.</p> </abstract>
APA, Harvard, Vancouver, ISO, and other styles
13

Sharma, Deepak, Sachin Lamba, Aakash Pandita, and Sweta Shastri. "Klippel–Trénaunay Syndrome – A Very Rare and Interesting Syndrome." Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 9 (January 2015): CCRPM.S21645. http://dx.doi.org/10.4137/ccrpm.s21645.

Full text
Abstract:
Klippel–Trénaunay syndrome (KTS or KT) is an infrequently seen dermatological syndrome, which is often viewed as a triad of vascular malformation (capillary malformations or port-wine brands), venous varicosity, and soft tissue and/or bony hypertrophy. We report a case of a 12-year-old male who presented to us with the symptoms of varicose plaques over both lower limbs and was diagnosed as a case of KTS. Management is normally conservative and includes stockings for compression of the branches to reduce edema because of chronic venous insufficiency; modern devices that cause on and off pneumat
APA, Harvard, Vancouver, ISO, and other styles
14

Eghbal Lahooran, Oilinia Bordovski, and Bonesch Tiora. "Extra-pulmonary manifestations of COVID-19: A comprehensive review." World Journal of Advanced Research and Reviews 23, no. 3 (2024): 562–69. http://dx.doi.org/10.30574/wjarr.2024.23.3.2720.

Full text
Abstract:
The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has predominantly been recognized for its respiratory impact. However, as the pandemic has progressed, it has become evident that SARS-CoV-2 affects multiple organ systems beyond the lungs, resulting in a wide array of extra-pulmonary manifestations. These manifestations encompass cardiovascular, neurological, gastrointestinal, hepatic, renal, dermatological, hematological, endocrine, musculoskeletal, ocular, immunological, and psychiatric complications. This review aims to provide a comprehensiv
APA, Harvard, Vancouver, ISO, and other styles
15

Eghbal, Lahooran, Bordovski Oilinia, and Tiora Bonesch. "Extra-pulmonary manifestations of COVID-19: A comprehensive review." World Journal of Advanced Research and Reviews 23, no. 3 (2024): 562–69. https://doi.org/10.5281/zenodo.14928879.

Full text
Abstract:
The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has predominantly been recognized for its respiratory impact. However, as the pandemic has progressed, it has become evident that SARS-CoV-2 affects multiple organ systems beyond the lungs, resulting in a wide array of extra-pulmonary manifestations. These manifestations encompass cardiovascular, neurological, gastrointestinal, hepatic, renal, dermatological, hematological, endocrine, musculoskeletal, ocular, immunological, and psychiatric complications. This review aims to provide a comprehensiv
APA, Harvard, Vancouver, ISO, and other styles
16

Sharma, Rohini, and Sameer Abrol. "Cutaneous adverse effects following COVID 19 precaution taking measures." IP Indian Journal of Clinical and Experimental Dermatology 8, no. 1 (2022): 8–11. http://dx.doi.org/10.18231/j.ijced.2022.002.

Full text
Abstract:
The outbreak of a mysterious pneumonia, reported from a sea food wet market of Wuhan, Hubei, China in 2019 has now taken the shape of a pandemic with successive waves sweeping across nations and creating havoc. Moreover, the transmission speed is much more than earlier severe acute respiratory syndrome coronavirus (SARS) and Middle East respiratory syndrome coronavirus (MERS) making it imperative for the use of protective gears like masks, gloves and personal protective equipment(PPE) kits but ironically they in itself lead to a range of cutaneous complications making it difficult to continuou
APA, Harvard, Vancouver, ISO, and other styles
17

Supekar, Bhagyashree Babanrao, Vaishali Hainath Wankhade, Shraddha P. Kote, et al. "Coronavirus Disease 2019 and Skin: A Retrospective Analysis." Clinical Dermatology Review 8, no. 3 (2024): 225–34. http://dx.doi.org/10.4103/cdr.cdr_117_22.

Full text
Abstract:
Abstract Introduction: Coronavirus disease 2019 (COVID-19), a unique viral infection causing multiorgan failure, can lead to diverse dermatological manifestations, unlike other viral exanthems. There is a scarcity of Indian literature describing these manifestations. Aims and Objectives: To study the dermatological manifestations due to COVID-19 infection. Materials and Methods: It was a retrospective analysis (6 month) of patients with dermatological manifestations related to COVID-19 infection. Medical records were evaluated with respect to demography, detailed clinical presentations, real-t
APA, Harvard, Vancouver, ISO, and other styles
18

Anwar, Muhammad U., and Reese H. Clark. "Section Review: Prevention and treatment of respiratory distress syndrome: Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis." Expert Opinion on Investigational Drugs 4, no. 7 (1995): 581–92. http://dx.doi.org/10.1517/13543784.4.7.581.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Alviariza, Annisa, and Luh M. Budiani. "Dermatologic manifestation of COVID-19: a systematic review." International Journal of Research in Dermatology 7, no. 4 (2021): 565. http://dx.doi.org/10.18203/issn.2455-4529.intjresdermatol20212554.

Full text
Abstract:
<p class="abstract">Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections, causing disease known as COVID-19, has been associated with a myriad of symptoms, including dermatological ones. Despite there has been a consensus on pulmonary and systemic signs and symptoms of COVID-19, the same cannot be said of dermatological ones. We write in attempt to find a common theme of dermatological manifestations of COVID-19. We conducted literature searches from Medline databases as well as Google Scholar using keywords “cutaneous manifestations of COVID-19” and “dermatologic mani
APA, Harvard, Vancouver, ISO, and other styles
20

Dosedla, Erik, Petra Gašparová, Zuzana Ballová, Kamila Radaljová, and Pavel Calda. "Epidermolysis in a newborn of a mother affected by covid-19 in the 3rd trimester of pregnancy." Česká gynekologie 88, no. 1 (2023): 13–16. http://dx.doi.org/10.48095/cccg202313.

Full text
Abstract:
Covid-19, caused by severe respiratory syndrome coronavirus 2 (SARS-CoV-2), is currently a pandemic. Although this infection primarily presents with respiratory symptoms, the number of reported extrapulmonary manifestations, including dermatological, is also increasing. A group of pregnant women is particularly susceptible to respiratory diseases, but with regard to covid-19, there is still limited data on the course of infection in pregnancy in relation to the possibility of vertical transmission. We present the case of a 30-year-old unvaccinated patient with a history of overcoming covid-19
APA, Harvard, Vancouver, ISO, and other styles
21

Błaszczyk, Agnieszka, Sara Trojan, Urszula Fussek-Styga, et al. "Sweet Syndrome - A Review of Pathogenesis, Clinical Features, Diagnosis and Treatment." Journal of Education, Health and Sport 30, no. 1 (2023): 45–56. http://dx.doi.org/10.12775/jehs.2023.30.01.004.

Full text
Abstract:
Sweet syndrome is a rare, inflammatory, non-infectious skin disorder characterized by an acute onset of skin leasions such as painful, erythematous plaques, nodules and papules, most frequently located on the upper extremities, trunk, neck and face. Generally, dermatological symptoms are accompanied by fever, headaches, arthralgia and leukocytosis. The syndrome belongs to the group of febrile neutrophilic dermatoses. Skin biopsy reveals a diffuse, neutrophilic infiltrate in the upper dermis. Sweet syndrome presents in three clinical subtypes: classical, malignancy-associated and drug-induced.
APA, Harvard, Vancouver, ISO, and other styles
22

John, Shaji Thomas, Gayathri K., Rizwana P., and Abhay M. Martin. "Reactive infectious mucocutaneous eruptions associated with SARS-CoV-2 infection." International Journal of Contemporary Pediatrics 9, no. 1 (2021): 132. http://dx.doi.org/10.18203/2349-3291.ijcp20214953.

Full text
Abstract:
Several dermatological manifestations are described in COVID-19. A 3-year-old boy presented with fever, painful oral ulcers with COVID-19 infection. A diagnosis of reactive infectious mucocutaneous eruptions (RIME) was made. He was worked up for the usual causes of RIME but were all negative. His severe acute respiratory syndrome corona virus-2 immunoglobulin M (SARS-CoV-2 IgM) was positive and he was managed with Intravenous hydrocortisone with which he improved dramatically. RIME might be the first/only manifestation of COVID-19 and it should be kept in mind.
APA, Harvard, Vancouver, ISO, and other styles
23

Marraha, Farah, Ibtissam Al Faker, and Salim Gallouj. "A Review of the Dermatological Manifestations of Coronavirus Disease 2019 (COVID-19)." Dermatology Research and Practice 2020 (August 11, 2020): 1–9. http://dx.doi.org/10.1155/2020/9360476.

Full text
Abstract:
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has affected 210 countries and territories around the world. The virus has spread rapidly, and the disease is still extending up to now. The pathophysiology for SARS-CoV-2 has not been well elucidated, and diverse hypotheses to date have been proposed. Initially, no skin manifestations were observed among patients with COVID-19, but recently a few cases have been described. In this review, we discuss these various cutaneous manifestations and skin problems related to personal protective e
APA, Harvard, Vancouver, ISO, and other styles
24

Tagore, Praveen K., Prashant Harit, Manish K. Sachan, Mahendra K. Bharti, Pratima Singh, and Gauri Harit. "Effect of Vitamins B12 and D Deficiency in Thyroid, Skin, Oral, and Respiratory Disease." Journal of Pharmacy and Bioallied Sciences 17, Suppl 2 (2025): S1749—S1751. https://doi.org/10.4103/jpbs.jpbs_300_25.

Full text
Abstract:
ABSTRACT Background: Vitamin B12 and vitamin D play crucial roles in maintaining metabolic and immune homeostasis. Deficiencies in these vitamins have been linked to multiple systemic and localized disorders, including thyroid dysfunction, dermatological conditions, oral pathologies, and respiratory diseases. Materials and Methods: A cross-sectional study was conducted on 200 participants aged 20–50 years, divided into two groups: individuals with vitamins B12 and D deficiencies (n = 100) and healthy controls (n = 100). Serum vitamin B12 and vitamin D levels were assessed using chemiluminescen
APA, Harvard, Vancouver, ISO, and other styles
25

Karimi, Abdollah, Elham Pourbakhtiaran, Mazdak Fallahi, Fereshteh karbasian, Shahnaz Armin, and Delara Babaie. "Is It Stevens–Johnson Syndrome or MIS-C with Mucocutaneous Involvement?" Case Reports in Pediatrics 2021 (December 24, 2021): 1–4. http://dx.doi.org/10.1155/2021/1812545.

Full text
Abstract:
Background. Severe acute respiratory syndrome coronavirus-2 (SARS-COV-2) can be present in the form of multisystem inflammatory disease in children. Case Presentation. A 25-month-old boy presented with fever, malaise, diffuse maculopapular rashes, and mucosal involvement during the COVID-19 pandemic. He was first diagnosed with Stevens–Johnson syndrome (SJS). Further evaluation revealed lymphopenia, thrombocytopenia, and elevated levels of C-reactive protein (CRP), ferritin, and fibrinogen. This was followed by a positive polymerase chain reaction (PCR) test for COVID-19. In addition to receiv
APA, Harvard, Vancouver, ISO, and other styles
26

Baj, Jacek, Hanna Karakuła-Juchnowicz, Grzegorz Teresiński, et al. "COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge." Journal of Clinical Medicine 9, no. 6 (2020): 1753. http://dx.doi.org/10.3390/jcm9061753.

Full text
Abstract:
Coronavirus disease 2019 (COVID-19), due to the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has become an epidemiological threat and a worldwide concern. SARS-CoV-2 has spread to 210 countries worldwide and more than 6,500,000 confirmed cases and 384,643 deaths have been reported, while the number of both confirmed and fatal cases is continually increasing. COVID-19 is a viral disease that can affect every age group—from infants to the elderly—resulting in a wide spectrum of various clinical manifestations. COVID-19 might present different degrees of severity—from mild or eve
APA, Harvard, Vancouver, ISO, and other styles
27

Baj, Jacek, Alicja Forma, Barbara Teresińska, et al. "How Does SARS-CoV-2 Affect Our Eyes—What Have We Learnt So Far about the Ophthalmic Manifestations of COVID-19?" Journal of Clinical Medicine 11, no. 12 (2022): 3379. http://dx.doi.org/10.3390/jcm11123379.

Full text
Abstract:
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection has become a worldwide threat resulting in a pandemic in 2020. SARS-CoV-2 infection manifests itself as coronavirus disease 2019 (COVID-19) that is evidenced in a vast number of either specific or nonspecific symptoms. Except for typical (but nonspecific) symptoms such as fever, dry cough, or muscle weakness, the infected patients might also present atypical symptoms including neurological, dermatological, or ophthalmic manifestations. This paper summarizes the current state of knowledge regarding the onset, progression
APA, Harvard, Vancouver, ISO, and other styles
28

Alsadi, Mohammed Omar, and Vinita John. "Dermatological Complications of COVID 19 Vaccines: An Updated Review." National Journal of Community Medicine 14, no. 03 (2023): 180–86. http://dx.doi.org/10.55489/njcm.140320232663.

Full text
Abstract:
Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the 2019 coronavirus disease (COVID-19) pandemic, have been rapidly developed and authorized. However, recent studies showed that COVID-19 vaccination is associated with a wide range of dermatological reactions. The most prevalent adverse dermatological reaction observed in observational studies was a delayed large local reaction (DLRs), which is characterized by the appearance of an erythematous and edematous patch at the injection site four days or more after vaccination. Most of these react
APA, Harvard, Vancouver, ISO, and other styles
29

Bandaru, Sougandhika, Sravan Chittla, Swetha Donakonda, and Dheeraj Sathaiahgari. "Dermatological Manifestations in COVID-19 and Post COVID-19 Patients: An Observational Study." International Journal of Pharmaceutical and Clinical Research 15, no. 3 (2023): 1471–79. https://doi.org/10.5281/zenodo.14564616.

Full text
Abstract:
<strong>Background:</strong>&nbsp;In December 2019, a new infection termed severe acute respiratory syndrome coronavirus 2 was recognised in Wuhan China. In literature only few studies exist on cutaneous manifestations in COVID-19 and post-COVID-19 phase. Hence the present study is conducted to know the most common cutaneous manifestations.&nbsp;<strong>Material &amp; Method:</strong>&nbsp;The present study included total of 60 patients presented with skin manifestations during COVID-19 and post COVID-19 phase of both in-patients and out-patients from October 2020 to June 2021. The patients ag
APA, Harvard, Vancouver, ISO, and other styles
30

Dr., Shubhangi DC, M.A Waheed2 Nameera Simran Dr., Simran Nameera, and Basavaraj Gadgay Dr. "Prediction and Categorization Of COVID-19 Related Dermatological Manifestations Using Machine Learning." Journal Of Scientific Research And Technology 1, no. 1 (2023): 1–8. https://doi.org/10.5281/zenodo.7863327.

Full text
Abstract:
<strong>COVID-19 is global epidemic instigated because of &quot;severe acute respiratory syndrome corona virus 2&quot; .Fever, cough, tiredness, dyspnea, and hypogeusia/ hyposmia are all common signs. Dermatological indications have become more common in recent months among the extrapulmonary indicators associated with COVID-19. &nbsp;Our group proposed a taxonomy based on the polymorphic character of COVID-19-related cutaneous symptoms, which includes the following six primary clinical patterns:Urticarial rash, confluent erythematous / maculopapular / morbilliform rash, papulovesicular exanth
APA, Harvard, Vancouver, ISO, and other styles
31

Kooragayalu, Shravan. "Rash in COVID-19." Journal of Clinical Case Reports and Studies 1, no. 6 (2020): 01–02. http://dx.doi.org/10.31579/2690-8808/018.

Full text
Abstract:
In December 2019, unexplained cases of pneumonia were reported in Wuhan, China. A novel coronavirus named Severe Acute Respiratory Syndrome coronavirus-2 (SARS CoV-2) was isolated from respiratory tract of patients, and the resultant disease was termed as COVID-19 (Coronavirus Disease 2019) (Jin YH 2020). COVID-19 has spread throughout china and across the world and it was declared as a pandemic by March 11th 2020 (Ng OT 2020). Running Title: COVID-19 is a systemic disease that could affect almost all parts of the body but it primarily affects the respiratory system. There is very limited data
APA, Harvard, Vancouver, ISO, and other styles
32

Al Faruk, Abdullah, and Mohammad Rifat Rahman. "Herpes Zoster associated With COVID-19 in an immunocompetent male." Update Dental College Journal 11, no. 2 (2021): 35–37. http://dx.doi.org/10.3329/updcj.v11i2.56096.

Full text
Abstract:
Severe acute respiratory syndrome coronavirus (SARS-COV-2) presented with pulmonary symptoms and various extra pulmonary manifestations including dermatological manifestations like urticarial, acralvascular lesion erythematous maculopapular rash, and vesicular rash. Herpes zoster is a painful vesicular rash resulting from reactivation of varicella-zoster (VZ) virus that also a causative agent of chickenpox. The incidence of HZ infection (HZI) more prevalent in older ages and various immunosuppressive conditions. Coronavirus disease in 2019(Covid19) causing immune exhaustion and VZ virus reacti
APA, Harvard, Vancouver, ISO, and other styles
33

Wollina, Uwe, Anca Chiriac, and Ayse Serap Karadag. "The Dermatological Spectrum of Coronavirus Disease-19 Disease: Cutaneous Signs for Diagnostics and Prognosis and an Expanded Classification." Open Access Macedonian Journal of Medical Sciences 8, T1 (2020): 294–303. http://dx.doi.org/10.3889/oamjms.2020.5091.

Full text
Abstract:
During severe acute respiratory syndrome coronavirus (CoV)-2- induced CoV disease (COVID)-19 pandemic cutaneous signs of the disease gained increasing interest for early diagnosis, to establish a prognosis and for differential diagnoses. The present review aims to summarize current knowledge on cutaneous findings in COVID-19. The findings are classified and described clinically. The spectrum of cutaneous signs include acro-ischemic lesions, rash, chilblain-like eruptions, and androgenetic alopecia. Their significance is given, and treatment options are presented. This may allow the clinicians
APA, Harvard, Vancouver, ISO, and other styles
34

Del Casale, Antonio, Stefano Ferracuti, Alessio Mosca, et al. "Multiple Chemical Sensitivity Syndrome: A Principal Component Analysis of Symptoms." International Journal of Environmental Research and Public Health 17, no. 18 (2020): 6551. http://dx.doi.org/10.3390/ijerph17186551.

Full text
Abstract:
Multiple Chemical Sensitivity (MCS) is a chronic and/or recurrent condition with somatic, cognitive, and affective symptoms following a contact with chemical agents whose concentrations do not correlate with toxicity in the general population. Its prevalence is not well defined; it mainly affects women between 40 and 50 years, without variations in ethnicity, education and economic status. We aimed to assess the core symptoms of this illness in a sample of Italian patients. Two physicians investigated different symptoms with a checklist compilation in 129 patients with MCS (117 women). We cond
APA, Harvard, Vancouver, ISO, and other styles
35

Gabriela, Badescu Anca, Chirila Sergiu, and Hangan Tony. "Postcovid Multisystemic Inflammatory Syndrome in a Child with Acute Obstructive Pneumonia." ARS Medica Tomitana 27, no. 1 (2021): 31–35. http://dx.doi.org/10.2478/arsm-2021-0007.

Full text
Abstract:
Abstract Childhood inflammatory multisystemic syndrome (CIS-C) is a serious late complication of SARS-CoV-2 infection that can develop in some children and young adults. Criteria for defining SIM-C in children include fever≥ 38.0°C, laboratory findings suggestive of an inflammatory process increased - C-reactive protein, D-dimer, VSH, ferritin, LDH, IL-6, neutrophils, procalcitonin, venous blood gas and lactate levels, brain natriuretic peptide; decreased - lymphocytes, platelets, serum albumin, serum sodium, manifestations of multisystem involvement with &gt;2 organs/systems (cardiac, renal,
APA, Harvard, Vancouver, ISO, and other styles
36

Paczwa, Katarzyna, Magdalena Rerych, Katarzyna Romanowska-Próchnicka, Radosław Różycki, and Joanna Gołębiewska. "Ocular Manifestation in Systemic Sclerosis—A Literature Review." Life 14, no. 5 (2024): 627. http://dx.doi.org/10.3390/life14050627.

Full text
Abstract:
Systemic sclerosis (SSc) is a chronic autoimmune connective tissue disease that affects more than 2 million people worldwide. It manifests through vasculopathy, an abnormal immunological response, and fibrosis leading to dysfunction of the multiple organs. The disease is categorized into two subtypes: limited cutaneous SSc and diffuse cutaneous SSc. Scleroderma can affect vital organs with respiratory, cardiac, renal, ocular, and dermatological complications. The ocular manifestations of the disease can occur in the anterior and posterior segments of the eye. Changes in the anterior segment re
APA, Harvard, Vancouver, ISO, and other styles
37

Thakur, Vikram, Radha Kanta Ratho, Pradeep Kumar, et al. "Multi-Organ Involvement in COVID-19: Beyond Pulmonary Manifestations." Journal of Clinical Medicine 10, no. 3 (2021): 446. http://dx.doi.org/10.3390/jcm10030446.

Full text
Abstract:
Coronavirus Disease 19 (COVID-19), due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has become an on-going global health emergency affecting over 94 million cases with more than 2 million deaths globally. Primarily identified as atypical pneumonia, it has developed into severe acute respiratory distress syndrome (ARDS), a multi-organ dysfunction with associated fatality. Ever since its emergence, COVID-19 with its plethora of clinical presentations has signalled its dynamic nature and versatility of the disease process. Being a disease with droplet transmission has now assum
APA, Harvard, Vancouver, ISO, and other styles
38

Ali, Zara, and Navneet Kalsi. "P032 Prevalence and severity of dermatological symptoms experienced after critical care admission: an observational study." British Journal of Dermatology 191, Supplement_1 (2024): i28—i29. http://dx.doi.org/10.1093/bjd/ljae090.059.

Full text
Abstract:
Abstract Recent medical advances mean that more people survive critical illnesses and intensive care unit (ICU) admissions. This has led to an uptick in reported physical, cognitive and mental health issues post-ICU (Hiser SL, Fatima A, Ali M et al. Post-intensive care syndrome (PICS): recent updates. J Intensive Care 2023; 11: 23). Despite existing research, dermatological symptoms post-ICU care have been overlooked. This study aims to assess the prevalence and extent of such symptoms in patients 1 month after ICU admission. Local approval was obtained for the study. We enrolled ICU patients
APA, Harvard, Vancouver, ISO, and other styles
39

Minna, Chang. "Pityriasis Rosea Induced by Fifth Dose of COVID-19 Vaccine: Case Report." International Journal in Pharmaceutical Sciences 2, no. 4 (2024): 779–85. https://doi.org/10.5281/zenodo.10988076.

Full text
Abstract:
COVID-19 vaccines and severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) infection have been associated with a variety of dermatological presentations, including pityriasis rosea (PR) and pityriasis rosea-like eruption (PR-LE) (1). Initial Phase III trials reported only localised injection-site dermatological reactions, but a number of case reports and series have since described generalised PR and PR-LE (7). Currently, all reported cases of PR following the COVID-19 vaccine have occurred after the first or second dose (1). We present a case of a 29-year-old female, who developed PR
APA, Harvard, Vancouver, ISO, and other styles
40

FNU Sunina, Rekha Bajaj, Maneesh Kumar, et al. "TREATMENT RESISTANT EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG-STRAUSS SYNDROME) WITH NEUROLOGICAL COMPLICATIONS: A CASE REPORT." Insights-Journal of Health and Rehabilitation 3, no. 3 (Health & Rehab) (2025): 97–102. https://doi.org/10.71000/32msh910.

Full text
Abstract:
Background: Eosinophilic Granulomatosis with Polyangiitis (EGPA), formerly known as Churg-Strauss Syndrome, is a rare autoimmune vasculitis affecting small- and medium-sized blood vessels. It is characterized by multisystem involvement, including respiratory, dermatological, and neurological manifestations. Neurological complications, such as mononeuritis multiplex and peripheral neuropathy, are reported in up to 70% of cases and can result in significant functional impairment. Standard treatments, including glucocorticoids and cyclophosphamide, may fail in refractory cases, necessitating alte
APA, Harvard, Vancouver, ISO, and other styles
41

Pinkosz, Michalina, Mateusz Szymański, and Monika Cendrowska-Pinkosz. "A patient infected with SARS-Cov-2 presents with DIHS syndrome induced by olanzapine: diagnostic difficulties." Postępy Higieny i Medycyny Doświadczalnej 77, no. 1 (2023): 99–106. http://dx.doi.org/10.2478/ahem-2023-0016.

Full text
Abstract:
Abstract Drug-induced hypersensitivity syndrome (DIHS) is a potentially life-threatening reaction. The pathology of DIHS has been connected with adverse reactions to drugs; however, it has been observed that viruses and other infectious factors may induce similar responses in the body. COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has recently become a major challenge for worldwide healthcare. The dermatological symptoms occur in approximately 5.95% of COVID-19 patients, however, they are not exclusively a manifestation of SARS-CoV-2 infection. Certain skin-re
APA, Harvard, Vancouver, ISO, and other styles
42

George, J., E. Sadiq, I. Moola, S. Maharaj, and A. Mochan. "Informal gold miners with mercury toxicity: Novel asymmetrical neurological presentations." South African Medical Journal 113, no. 12 (2023): 20. http://dx.doi.org/10.7196/samj.2023.v113i12.1127.

Full text
Abstract:
Mercury is a highly toxic heavy metal that may cause neurological, respiratory, gastrointestinal and dermatological illnesses. Previously described neurological manifestations of mercury toxicity are symmetrical, and include a pancerebellar syndrome, generalised seizures and encephalopathy. Mercury is used in the gold mining process, and in artisanal or illicit gold mining, often without necessary protection. Here we describe the cases of two artisanal gold miners from western Johannesburg, South Africa, who presented with atypical neurological manifestations of mercury toxicity. Patient 1 pre
APA, Harvard, Vancouver, ISO, and other styles
43

Masood, Waniyah, Shahzaib Ahmad, Noor Ayman Khan, et al. "Pathobiology of Cutaneous Manifestations Associated with COVID-19 and Their Management." Viruses 14, no. 9 (2022): 1972. http://dx.doi.org/10.3390/v14091972.

Full text
Abstract:
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19) has been a rising concern since its declaration as a pandemic by the World Health Organization on 11 March 2020. Recently, its association with multiple underlying organs has been identified that includes cardiac, renal, gastrointestinal, nervous systems, and cutaneous manifestations. Cutaneous COVID-19 findings have been supposedly classified into the following categories: vesicular (varicella-like), papulo-vesiculsar, chilblains-like (“COVID toes”) maculopapular, and urticarial morphologi
APA, Harvard, Vancouver, ISO, and other styles
44

Maldonado, Valente, Grecia Figueroa Ramos, Etna Laura Guerrero Sánche, and Valeria Álvarez Rivero. "Dermatomiositis Anti-Mda5 Positive Report of a Case and Literature Review." Dermatology and Dermatitis 5, no. 2 (2020): 01–10. http://dx.doi.org/10.31579/2578-8949/069.

Full text
Abstract:
Dermatomyositis (DM) is an autoimmune connective tissue disorder with characteristic skin changes and involvement of different organs and systems, such as muscle, cardiovascular, respiratory and gastrointestinal systems. This condition is characterized by the presence of a myopathic syndrome with bilateral and symmetric weakness predominantly of extensor, proximal muscle groups, respiratory muscles and esophageal involvement, accompanied by characteristic skin disorders. The worldwide incidence is reported at 1 to 6 cases per million inhabitants; predominates in women, with 2.5:1 ratio; and ha
APA, Harvard, Vancouver, ISO, and other styles
45

Akalu, Suchitra D., and Niveditha G. Belavadi. "Pattern of adverse drug reaction to antiepileptic drugs in a tertiary care hospital." International Journal of Basic & Clinical Pharmacology 6, no. 9 (2017): 2219. http://dx.doi.org/10.18203/2319-2003.ijbcp20173748.

Full text
Abstract:
Background: Adverse drug reactions (ADRs) are a major cause of morbidity and mortality, and are the leading cause of hospital admission. The overall rate of ADRs is estimated to be 6.5% and 28% of these ADRs are preventable. Antiepileptic drugs (AEDs) are authorized for several therapeutic indications and are highly prescribed. ADRs due to AEDs range from minor maculopapular exanthem (MPE) to severe life-threatening reactions like Drug reaction eosinophilia and systemic symptoms (DRESS) and Stevens-Johnson syndrome (SJS). Objective of the study was to evaluate the pattern of ADRs reported with
APA, Harvard, Vancouver, ISO, and other styles
46

Tambekar, Harish J., Satish D. Ashtekar, Shishir P. Mirgunde, Swati Khot, and Shrikant Mane. "Neonatal multisystem inflammatory syndrome associated with prenatal maternal SARS-CoV-2 exposure: a case series." International Journal of Contemporary Pediatrics 9, no. 4 (2022): 381. http://dx.doi.org/10.18203/2349-3291.ijcp20220766.

Full text
Abstract:
Multisystem inflammatory syndrome (MIS-C) in children (MIS-C) associated with severe acute respiratory syndrome coronavirus-2 (SARS-CoV2) is well recognised in children, however, rarely reported in newborns. It usually presents as fever and multiorgan involvement, with blood investigations showing increased inflammatory markers weeks after exposure to SARS-CoV-2. Unlike older children, the mechanism is unique in neonates as COVID-19 infection and the subsequent inflammatory reaction leading to MIS-C occur in two different individuals. We reviewed the perinatal history, clinical features, and o
APA, Harvard, Vancouver, ISO, and other styles
47

Aristizabal, Ana M., Carlos A. Guzmán-Serrano, Camila Ariza-Insignares, Gerardo Guzmán, Claudia Guerrero, and Cesar Cely. "Ventricular Dysfunction Secondary to Refeeding Syndrome in an Infant, A Case Report." International Journal of Child Health and Nutrition 13, no. 4 (2024): 220–24. http://dx.doi.org/10.6000/1929-4247.2024.13.04.3.

Full text
Abstract:
Introduction: Refeeding syndrome is a complex of signs and symptoms that occur following the abrupt initiation of enteral or parenteral nutrition in malnourished patients, among other causes. Most data focuses on adolescents and adults, with limited neonatal information and other pediatric group ages. This case presents an infant who developed ventricular dysfunction due to refeeding syndrome following starvation. Case Report: A 5-month-old female with a one-month history of generalized maculopapular rash and lower limb edema. Physical examination revealed severe malnutrition and significant e
APA, Harvard, Vancouver, ISO, and other styles
48

Fawcett, Anne, Vanessa Barrs, Magdoline Awad, et al. "Consequences and Management of Canine Brachycephaly in Veterinary Practice: Perspectives from Australian Veterinarians and Veterinary Specialists." Animals 9, no. 1 (2018): 3. http://dx.doi.org/10.3390/ani9010003.

Full text
Abstract:
This article, written by veterinarians whose caseloads include brachycephalic dogs, argues that there is now widespread evidence documenting a link between extreme brachycephalic phenotypes and chronic disease, which compromises canine welfare. This paper is divided into nine sections exploring the breadth of the impact of brachycephaly on the incidence of disease, as indicated by pet insurance claims data from an Australian pet insurance provider, the stabilization of respiratory distress associated with brachycephalic obstructive airway syndrome (BOAS), challenges associated with sedation an
APA, Harvard, Vancouver, ISO, and other styles
49

Gentile, Pietro. "Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies." International Journal of Molecular Sciences 23, no. 16 (2022): 9116. http://dx.doi.org/10.3390/ijms23169116.

Full text
Abstract:
The diffusion of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inducing coronavirus disease 2019 (COVID-19) has increased the incidence of several dermatological disorders, including hair loss (HL). This article aims to review the literature regarding the incidence of HL and telogen effluvium (TE) in COVID-19 patients and critically appraise the available evidence regarding the role of regenerative strategies like Platelet-Rich Plasma (PRP) and Human Follicle Stem Cells (HFSCs). A literature review regarding the correlation of HL and TE in COVID-19 patients analyzing the biomole
APA, Harvard, Vancouver, ISO, and other styles
50

Rosales Torres, Pedro, and Pedro León Acosta. "Lymphomatoid granulomatosis with infrequent manifestations: case report." Hematology & Transfusion International Journal 11, no. 4 (2023): 105–8. http://dx.doi.org/10.15406/htij.2023.11.00315.

Full text
Abstract:
Introduction: lymphomatoid granulomatosis is a very rare disease with few reports in the medical literature. Objective: to present the case of a lymphomatoid granulomatosis that constitutes a variety of primary lymphoproliferative neoplasms of the lung and constitutes the first case reported in our hospital. Case presentation: 44-year-old male, veterinarian with a history of health without toxic habits that began with respiratory symptoms, dermatological lesions, constitutional syndrome and flaccid paraplegia. After performing the essential complementary tests which showed pancytopenia; an ima
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!